Evidence map›Paper›PMID 27320390›Full record

ArticleScientific reports2016

Cholecystectomy is associated with higher risk of early recurrence and poorer survival after curative resection for early stage hepatocellular carcinoma.

Tao Li, Shu-Kang Wang, Xu-Ting Zhi, Jian Zhou, Zhao-Ru Dong, Zong-Li Zhang, Hui-Chuan Sun, Qing-Hai Ye, Jia Fan

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Tao LiDepartment of General Surgery, Qilu Hospital, Shandong University, Jinan, P.R. China.
Shu-Kang WangDepartment of Biostatistics, School of Public Health, Shandong University, Jinan, P.R. China.
Xu-Ting ZhiDepartment of General Surgery, Qilu Hospital, Shandong University, Jinan, P.R. China.
Jian ZhouLiver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, P.R. China.
Zhao-Ru DongDepartment of General Surgery, Qilu Hospital, Shandong University, Jinan, P.R. China.
Zong-Li ZhangDepartment of General Surgery, Qilu Hospital, Shandong University, Jinan, P.R. China.
Hui-Chuan SunLiver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, P.R. China.
Qing-Hai YeLiver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, P.R. China.
Jia FanLiver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, P.R. China.
Qilu Hospital of Shandong University · CNZhongshan Hospital · CNFudan University · CNShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although cholecystectomy has been reported to be associated with increased risk of developing hepatocellular carcinoma (HCC), the association between cholecystectomy and prognosis of HCC patients underwent curative resection has never been examined. Through retrospective analysis of the data of 3933 patients underwent curative resection for HCC, we found that cholecystectomy was an independent prognostic factor for recurrence-free survival (RFS) of patients at early stage (BCLC stage 0/A) (p = 0.020, HR: 1.29, 95% CI: 1.04-1.59), and the 1-, 3-, 5-year RFS rates for patients at early stage were significantly worse in cholecystectomy group than in non-cholecystectomy group (80.5%, 61.8%, 52.0% vs 88.2%, 68.8%, 56.8%, p = 0.033). The early recurrence rate of cholecystectomy group was significantly higher than that of non-cholecystectomy group for patients at early stage (59/47 vs 236/333, p = 0.007), but not for patients at advanced stage (BCLC stage C) (p = 0.194). Multivariate analyses showed that cholecystectomy was an independent risk factor for early recurrence (p = 0.005, HR: 1.52, 95% CI: 1.13-2.03) of early stage HCC, but not for late recurrence (p = 0.959). In conclusion, cholecystectomy is an independent predictor for early recurrence and is associated with poorer RFS of early stage HCC. Removal of normal gallbladder during HCC resection may be avoided for early stage patients.

Indexed as

Carcinoma, HepatocellularCholecystectomyDisease-Free SurvivalFemaleGallbladderGallbladder NeoplasmsHumansLiver NeoplasmsMaleMiddle AgedNeoplasm Recurrence, LocalRetrospective StudiesRisk Factors

Identifiers

PMID27320390
PMCPMC4913319
OpenAlexW2475250083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.